HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
CVAC
CureVac N.V.
Healthcare Biotechnology ADR · Germany · Reports in eur
Market Cap: $1.05B
Market Cap
$1.05B
Enterprise Val
$595.5M
P/E Ratio
6.90
P/B Ratio
1.02
Trailing PEG (1Y)
-0.35
As Of
Apr 15, 2026

Overview & Key Metrics

Reporting period: Sep 30, 2025 · Q3 2025
Book Value$1.02B
Gross Margin99.31%
Profit Margin99.31%
Return on Equity18.40%
Return on Assets15.28%
Current Ratio3.70
Debt/Equity0.04
LT Debt/Equity0.03
Revenue Per Share0.28

Income Statement

Sep 30, 2025
Revenue$63.7M
Cost of Revenue$441.2K
Gross Profit$63.2M
R&D$45.0M
SG&A$29.9M
Operating Expenses-$301.7M
Operating Income$365.0M
Interest Expense$7.0M
Tax Expense$40.4M
Net Income$321.4M
EPS (Basic)$1.42
EPS (Diluted)$1.42
EBIT$368.8M
EBITDA$374.0M
Consolidated Income$321.4M
Non-Controlling Interests$0.00

Balance Sheet

Sep 30, 2025
Cash & Equivalents$489.5M
Accounts Receivable$23.1M
Inventory$636.5K
Current Assets$1.03B
LT Investments$0.00
Property, Plant & Equipment$277.2M
Intangibles$29.0M
Non-Current Assets$312.4M
Total Assets$1.34B
Accounts Payable$10.3M
Current Debt$5.6M
Current Liabilities$277.8M
LT Debt$35.6M
Non-Current Liabilities$36.7M
Total Liabilities$314.6M
Total Debt$41.3M
Retained Earnings-$1.46B
Shareholder Equity$1.02B
Shares Outstanding225,172,749

Cash Flow Statement

Sep 30, 2025
Operating Cash Flow$35.1M
Investing Cash Flow-$378.8K
Financing Cash Flow-$1.5M
CapEx-$284.7K
Free Cash Flow$34.8M
Depreciation & Amort.$5.1M
Stock-Based Comp$1.7M
Debt Issued/Repaid-$1.5M
Equity Issued/Repaid$0.00
Net Change in Cash$33.2M
Data cached · Meta live · Daily live · Statements live · TTL 24h